Response of angiogenic factors to the treatment with melatonin in breast cancer cell lines.

被引:0
作者
Jardim, Bruna Victorasso
Moschetta, Marina Gobbe
Borin, Thaiz Ferraz
Gelaleti, Gabriela Bottaro
Leonel, Camila
Ferreira, Livia Carvalho
Lopes, Juliana Ramos
Maschio, Larissa Bazela
Goncalves, Naiane do Nascimento
Aparecida, Debora
Zuccari, Pires de Campos
机构
[1] Univ Estadual Paulista, Sao Jose Do Rio Preto, Brazil
[2] Fac Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil
关键词
D O I
10.1200/jco.2012.30.27_suppl.120
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
120
引用
收藏
页数:1
相关论文
共 50 条
[41]   Dasatinib shows different cytotoxicity in triple-negative breast cancer cell lines. [J].
Haga, Yuya ;
Higashisaka, Kazuma ;
Yang, Lili ;
Sekine, Naoki ;
Nagano, Kazuya ;
Tsutsumi, Yasuo .
MOLECULAR CANCER RESEARCH, 2018, 16 (08) :27-28
[42]   Cilengitide induces apoptosis and reduces cell viability in breast cell lines. [J].
Perry, James D. ;
Peereboom, David ;
Chakravarti, Arnab ;
Lautenschlaeger, Tim .
CANCER RESEARCH, 2013, 73 (08)
[43]   Angiogenic factors and laminin expression in cervical cancer: correlation with treatment response [J].
Sharma, M. ;
Khan, R. ;
Sharma, A. ;
Aggarwal, M. ;
Sharma, A. .
ANNALS OF ONCOLOGY, 2015, 26 :12-12
[44]   Effect of astaxanthin and melatonin on cell viability and DNA damage in human breast cancer cell lines [J].
Karimian, Aida ;
Mohammadrezaei, Fereshteh Mir ;
Moghadam, Akbar Hajizadeh ;
Bahadori, Mohammad Hadi ;
Ghorbani-Anarkooli, Marjan ;
Asadi, Asadollah ;
Abdolmaleki, Arash .
ACTA HISTOCHEMICA, 2022, 124 (01)
[45]   PREDICTORS OF MEK INHIBITOR RESPONSE IN LOW GRADE SEROUS OVARIAN CANCER CELL LINES. [J].
Carey, M. ;
Dawson, A. ;
Hoenisch, J. ;
Kim, H. ;
Chui, K. ;
Bamford, S. ;
Salamanca, C. ;
Cremona, M. ;
Anderson, S. ;
Volik, S. ;
Le Bihan, S. ;
Collins, C. ;
Morin, G. ;
Huntsman, D. ;
DiMattia, G. ;
Hennessy, B. ;
Llaurado-Fernandez, M. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 :135-135
[46]   The evaluation of angiogenic inhibitory effect of RNA interference in vitro in breast cancer cell lines [J].
Neagoe, Ioana Berindan ;
Tudoran, Oana ;
Balacescu, O. ;
Balacescu, Loredana ;
Achimas, P. ;
Cristea, V. .
HUMAN GENE THERAPY, 2008, 19 (10) :1110-1110
[47]   CELL BIOLOGICAL FACTORS ASSOCIATED WITH THE RESPONSE OF BREAST-CANCER TO SYSTEMIC TREATMENT [J].
KLIJN, JGM ;
BERNS, EMJJ ;
BONTENBAL, M ;
FOEKENS, J .
CANCER TREATMENT REVIEWS, 1993, 19 :45-63
[48]   Identification of a novel truncated progesterone receptor (PR-M) in breast cancers and breast cancer cell lines. [J].
Garde, RV ;
Saner, CN ;
Price, TM .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) :171A-171A
[49]   Transcriptional regulation of protease-inhibitor maspin in breast epithelial- and breast cancer-cell lines. [J].
Maass, N ;
Zhang, M ;
Sager, R ;
Jonat, W .
TUMORDIAGNOSTIK & THERAPIE, 1997, 18 (04) :89-96
[50]   RIN1 expression in breast tumor cell lines. [J].
Patel, A ;
Newman, ST ;
Colicelli, J .
JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) :53A-53A